{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T23:22:57Z","timestamp":1777936977743,"version":"3.51.4"},"reference-count":40,"publisher":"Japanese Society of Internal Medicine","issue":"20","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2022,10,15]]},"DOI":"10.2169\/internalmedicine.9228-21","type":"journal-article","created":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T22:26:11Z","timestamp":1665786371000},"page":"3045-3052","source":"Crossref","is-referenced-by-count":7,"title":["Heterogeneity of Stroke in Patients with Systemic Lupus Erythematosus"],"prefix":"10.2169","volume":"61","author":[{"given":"Takaya","family":"Kitano","sequence":"first","affiliation":[{"name":"Department of Neurology, Osaka University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Hirano","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuhei","family":"Okazaki","sequence":"additional","affiliation":[{"name":"Department of Neurology, Osaka University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eri","family":"Itotagawa","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiki","family":"Yagita","sequence":"additional","affiliation":[{"name":"Department of Stroke Medicine, Kawasaki Medical School, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitaka","family":"Morita","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Kawasaki Medical School, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Neurology, Osaka Minami Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Osaka Minami Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manabu","family":"Sakaguchi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Osaka General Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Fujiwara","sequence":"additional","affiliation":[{"name":"Division of Rheumatology and Allergy, Osaka General Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Todo","sequence":"additional","affiliation":[{"name":"Department of Neurology, Osaka University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Sasaki","sequence":"additional","affiliation":[{"name":"Department of Neurology, Osaka University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Kumanogoh","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Mochizuki","sequence":"additional","affiliation":[{"name":"Department of Neurology, Osaka University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Bertsias GK, Boumpas DT. Pathogenesis, diagnosis and management of neuropsychiatric SLE manifestations. Nature Rev Rheumatol 6: 358-367, 2010.","DOI":"10.1038\/nrrheum.2010.62"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Hanly JG, Su L, Farewell V, McCurdy G, Fougere L, Thompson K. Prospective study of neuropsychiatric events in systemic lupus erythematosus. J Rheumatol 36: 1449-1459, 2009.","DOI":"10.3899\/jrheum.081133"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Mok CC, To CH, Mak A. Neuropsychiatric damage in Southern Chinese patients with systemic lupus erythematosus. Medicine 85: 221-228, 2006.","DOI":"10.1097\/01.md.0000231955.08350.1b"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Zhou HQ, Zhang FC, Tian XP, et al. Clinical features and outcome of neuropsychiatric lupus in Chinese: analysis of 240 hospitalized patients. Lupus 17: 93-99, 2008.","DOI":"10.1177\/0961203307085671"},{"key":"5","unstructured":"5. Hanly JG, Urowitz MB, Su L, et al. Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus. Ann Rheum Dis 69: 529-535, 2010."},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Brey RL, Holliday SL, Saklad AR, et al. Neuropsychiatric syndromes in lupus: prevalence using standardized definitions. Neurology 58: 1214-1220, 2002.","DOI":"10.1212\/WNL.58.8.1214"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Hanly JG, Li Q, Su L, et al. Cerebrovascular events in systemic lupus erythematosus: results from an international inception cohort study. Arthritis Care Res (Hoboken) 70: 1478-1487, 2018.","DOI":"10.1136\/lupus-2018-lsm.53"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Cervera R, Khamashta MA, Font J, et al. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine 82: 299-308, 2003.","DOI":"10.1097\/01.md.0000091181.93122.55"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Arkema EV, Svenungsson E, Von Euler M, Sj\u00f6wall C, Simard JF. Stroke in systemic lupus erythematosus: a Swedish population-based cohort study. Ann Rheum Dis 76: 1544-1549, 2017.","DOI":"10.1136\/annrheumdis-2016-210973"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Wiseman SJ, Ralston SH, Wardlaw JM. Cerebrovascular disease in rheumatic diseases. Stroke 47: 943-950, 2016.","DOI":"10.1161\/STROKEAHA.115.012052"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Holmqvist M, Simard JF, Asplund K, Arkema EV. Stroke in systemic lupus erythematosus: a meta-analysis of population-based cohort studies. RMD Open 1: e000168, 2015.","DOI":"10.1136\/rmdopen-2015-000168"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Conen KL, Jeanneret C, Hecker B, Cathomas G, Biedermann BC. Acute occlusive large vessel disease leading to fatal stroke in a patient with systemic lupus erythematosus: arteritis or atherosclerosis? Arthritis Rheum 54: 908-913, 2006.","DOI":"10.1002\/art.21656"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Kitano T, Sengoku K, Itotagawa E, Todo K. Dynamic morphological changes in Libman-Sacks endocarditis under different anticoagulation regimens. BMJ Case Rep 12: e229909, 2019.","DOI":"10.1136\/bcr-2019-229909"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Mitsias P, Levine SR. Large cerebral vessel occlusive disease in systemic lupus erythematosus. Neurology 44: 385-393, 1994.","DOI":"10.1212\/WNL.44.3_Part_1.385"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Kitagawa Y, Gotoh F, Koto A, Okayasu H. Stroke in systemic lupus erythematosus. Stroke 21: 1533-1539, 1990.","DOI":"10.1161\/01.STR.21.11.1533"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16. Mikdashi J, Handwerger B, Langenberg P, Miller M, Kittner S. Baseline disease activity, hyperlipidemia, and hypertension are predictive factors for ischemic stroke and stroke severity in systemic lupus erythematosus. Stroke 38: 281-285, 2007.","DOI":"10.1161\/01.STR.0000254476.05620.14"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Nikolopoulos D, Fanouriakis A, Boumpas DT. Cerebrovascular events in systemic lupus erythematosus: diagnosis and management. Mediterr J Rheumatol 30: 7-15, 2019.","DOI":"10.31138\/mjr.30.1.7"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40: 1725, 1997.","DOI":"10.1002\/art.1780400928"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Rannikm\u00e4e K, Woodfield R, Anderson CS, et al. Reliability of intracerebral hemorrhage classification systems: a systematic review. Int J Stroke 11: 626-636, 2016.","DOI":"10.1177\/1747493016641962"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Ay H, Furie KL, Singhal A, Smith WS, Sorensen AG, Koroshetz WJ. An evidence-based causative classification system for acute ischemic stroke. Ann Neurol 58: 688-697, 2005.","DOI":"10.1002\/ana.20617"},{"key":"21","unstructured":"21. Gladman DD, Urowitz MB, Kagal A, Hallett D. Accurately describing changes in disease activity in systemic lupus erythematosus. J Rheumatol 27: 377-379, 2000."},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Bortoluzzi A, Scire CA, Bombardieri S, et al. Development and validation of a new algorithm for attribution of neuropsychiatric events in systemic lupus erythematosus. Rheumatology (Oxford) 54: 891-898, 2015.","DOI":"10.1093\/rheumatology\/keu384"},{"key":"23","doi-asserted-by":"publisher","unstructured":"23. Adams HP Jr., Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24: 35-41, 1993.","DOI":"10.1161\/01.STR.24.1.35"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Doria A, Shoenfeld Y, Wu R, et al. Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus. Ann Rheum Dis 62: 1071-1077, 2003.","DOI":"10.1136\/ard.62.11.1071"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Devinsky O, Petito CK, Alonso DR. Clinical and neuropathological findings in systemic lupus erythematosus: the role of vasculitis, heart emboli, and thrombotic thrombocytopenic purpura. Ann Neurol 23: 380-384, 1988.","DOI":"10.1002\/ana.410230411"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Ellis SG, Verity MA. Central nervous system involvement in systemic lupus erythematosus: a review of neuropathologic findings in 57 cases, 1955--1977. Seminars Arthritis Rheum 8: 212-221, 1979.","DOI":"10.1016\/S0049-0172(79)80009-8"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Chimowitz MI, Lynn MJ, Derdeyn CP, et al. Stenting versus aggressive medical therapy for intracranial arterial stenosis. New Engl J Med 365: 993-1003, 2011.","DOI":"10.1056\/NEJMoa1105335"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Toloza SM, Uribe AG, McGwin G Jr., et al. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXIII. Baseline predictors of vascular events. Arthritis Rheum 50: 3947-3957, 2004.","DOI":"10.1002\/art.20622"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Mikdashi J, Handwerger B. Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort. Rheumatology (Oxford) 43: 1555-1560, 2004.","DOI":"10.1093\/rheumatology\/keh384"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Roldan CA, Gelgand EA, Qualls CR, Sibbitt WL Jr. Valvular heart disease as a cause of cerebrovascular disease in patients with systemic lupus erythematosus. Am J Cardiol 95: 1441-1447, 2005.","DOI":"10.1016\/j.amjcard.2005.02.010"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Fujieda Y, Amengual O. New insights into the pathogenic mechanisms and treatment of arterial thrombosis in antiphospholipid syndrome. Eur J Rheumatol 8: 93-99, 2020.","DOI":"10.5152\/eurjrheum.2020.20058"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Roldan CA, Shively BK, Crawford MH. An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus. N Engl J Med 335: 1424-1430, 1996.","DOI":"10.1056\/NEJM199611073351903"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Roldan CA, Sibbitt WL Jr., Qualls CR, et al. Libman-Sacks endocarditis and embolic cerebrovascular disease. JACC Cardiovasc Imaging 6: 973-983, 2013.","DOI":"10.1016\/j.jcmg.2013.04.012"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Roh D, Boehme A, Young C, et al. Hematoma expansion is more frequent in deep than lobar intracerebral hemorrhage. Neurology 95: e3386-e3393, 2020.","DOI":"10.1212\/WNL.0000000000010990"},{"key":"35","doi-asserted-by":"publisher","unstructured":"35. Inagawa T, Ohbayashi N, Takechi A, Shibukawa M, Yahara K. Primary intracerebral hemorrhage in Izumo city, Japan: incidence rates and outcome in relation to the site of hemorrhage. Neurosurgery 53: 1283-1298, 2003.","DOI":"10.1227\/01.NEU.0000093825.04365.F3"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Gross BA, Jankowitz BT, Friedlander RM. Cerebral intraparenchymal hemorrhage: a review. JAMA 321: 1295-1303, 2019.","DOI":"10.1001\/jama.2019.2413"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Boura P, Papadopoulos S, Tselios K, et al. Intracerebral hemorrhage in a patient with SLE and catastrophic antiphospholipid syndrome (CAPS): report of a case. Clin Rheumatol 24: 420-424, 2005.","DOI":"10.1007\/s10067-004-1062-9"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Arinuma Y, Kikuchi H, Aramaki K, Kyogoku M, Hirohata S. Histopathological analysis of cerebral hemorrhage in systemic lupus erythematosus complicated with antiphospholipid syndrome. Mod Rheumatol 21: 509-513, 2011.","DOI":"10.1007\/s10165-011-0420-0"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Ramagopalan SV, Pakpoor J, Seminog O, Goldacre R, Graham L, Goldacre MJ. Risk of subarachnoid haemorrhage in people admitted to hospital with selected immune-mediated diseases: record-linkage studies. BMC Neurol 13: 176, 2013.","DOI":"10.1186\/1471-2377-13-176"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Z\u00f6ller B, Li X, Sundquist J, Sundquist K. Risk of subsequent ischemic and hemorrhagic stroke in patients hospitalized for immune-mediated diseases: a nationwide follow-up study from Sweden. BMC Neurol 12: 41, 2012.","DOI":"10.1186\/1471-2377-12-41"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/20\/61_9228-21\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,15]],"date-time":"2022-10-15T03:25:53Z","timestamp":1665804353000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/20\/61_9228-21\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,15]]},"references-count":40,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.9228-21","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,15]]},"article-number":"9228-21"}}